DREXEL UNIVERSITY

Alzheimer’s patients on five or more daily meds face increased risk of symptoms, falls, hospitalizations, and death, per study in Biological Research for Nursing. Researchers call for tailored strategies to manage polypharmacy in this population.

Legend Biotech to open R&D center in Philadelphia, employing 55 staff, highlighting the city's growing biotech hub status.

Republicans are laying the groundwork for a federal abortion ban, despite their claims of state control. Three Republican attorneys general are refiling a case to challenge the FDA's approval of the abortion pill mifepristone, aiming to secure a favorable judge. The ultimate goal is to ban abortion nationally, using laws like the Comstock Act to restrict access to abortion medication and supplies.

Abortions in the U.S. have increased since Roe v. Wade was overturned, with telehealth access to medication abortion playing a significant role, especially in states with bans.

AAVantgarde Bio appoints Lauren Kaskiel, MBA, as Chief Business Officer, leveraging her 20+ years of biotech and pharma experience to enhance business development and pipeline advancement.

Erica Ollmann Saphire's $49 million project, America’s SHIELD, aims to develop vaccines for herpesviruses, addressing viral latency and multiple infection mechanisms. The initiative involves a consortium of researchers to tackle the complexity of herpesviruses, focusing on molecular structures, viral genomes, and immune signatures, with potential to significantly impact public health.

Alzheimer's Disease (AD) care faces barriers like stigma, lack of awareness, and health disparities, impacting diagnosis and management. Interventions such as resistance exercise training and tailored programs improve quality of life for patients and caregivers. Future care should focus on integrated teams and a patient-centered approach to address cognitive decline and support diverse populations.

A Drexel-led study, part of the Sidney Kimmel Comprehensive Cancer Center Research Consortium, showed significant improvements in participants' food choices after engaging with a coach. The study highlights the importance of behavioral science in helping adults make healthy choices, underscoring the need for interdisciplinary collaboration in cancer research and prevention. The consortium, recently awarded comprehensive status by the National Cancer Institute, leverages the expertise of multiple Drexel colleges and Thomas Jefferson University to develop transformative approaches in cancer prevention and treatment.